Surgery Partners (SGRY) Cost of Revenue (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Cost of Revenue data on file, last reported at $220.2 million in Q1 2026.

• Quarterly Cost of Revenue rose 405.05% year-over-year to $220.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $378.0 million (up 4.94% YoY) and the FY2025 annual result came in at $201.4 million, down 75.22% from the prior year.
• Cost of Revenue rose to $220.2 million in Q1 2026 per SGRY's latest filing, from $53.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $592.9 million in Q4 2022, with the low at -$374.5 million in Q4 2023.
• Average Cost of Revenue over 5 years is $73.8 million, with a median of $45.6 million recorded in 2023.
• Year-over-year, Cost of Revenue jumped 1648.97% in 2022 and tumbled 163.16% in 2023.
• Surgery Partners' Cost of Revenue stood at $592.9 million in 2022, then plunged by 163.16% to -$374.5 million in 2023, then jumped by 159.55% to $223.0 million in 2024, then sank by 76.05% to $53.4 million in 2025, then jumped by 312.36% to $220.2 million in 2026.
• Business Quant data shows SGRY's Cost of Revenue at $220.2 million in Q1 2026, $53.4 million in Q4 2025, and $49.0 million in Q3 2025.